Literature DB >> 11135350

Adjusting for drop-out in clinical trials with repeated measures: design and analysis issues.

M C Wu1, P S Albert, B U Wu.   

Abstract

Recently, Wu and Follmann developed summary measures to adjust for informative drop-out in longitudinal studies where drop-out depends on the underlying true value of the response. In this paper we evaluate these procedures in the common situation where drop-out depends on the observed responses. We also discuss various design and analysis strategies which minimize the bias obtained with this type of drop-out. Of particular interest is the use of multiple measurements of the response at each visit to reduce bias. These strategies are evaluated with a simulation study. The results are highlighted with applications to both a hypertensive and a respiratory disease clinical trial, where multiple measurements of the primary response were made for all participants at each visit. Copyright 2001 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11135350     DOI: 10.1002/1097-0258(20010115)20:1<93::aid-sim655>3.0.co;2-2

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  4 in total

1.  Tracking inner city substance users from the emergency department: how many contacts does it take?

Authors:  Rebecca Cunningham; Maureen A Walton; Shanti P Tripathi; Ryan Outman; Regan Murray; Brenda M Booth
Journal:  Acad Emerg Med       Date:  2008-02       Impact factor: 3.451

2.  Suggested statistical reporting guidelines for clinical trials data.

Authors:  Jaykaran Charan; Deepak Saxena
Journal:  Indian J Psychol Med       Date:  2012-01

3.  Problems in dealing with missing data and informative censoring in clinical trials.

Authors:  Weichung Shih
Journal:  Curr Control Trials Cardiovasc Med       Date:  2002-01-08

4.  Using a Counting Process Method to Impute Censored Follow-Up Time Data.

Authors:  Jimmy T Efird; Charulata Jindal
Journal:  Int J Environ Res Public Health       Date:  2018-04-05       Impact factor: 3.390

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.